Difference between revisions of "TG002972"
Jump to navigation
Jump to search
(Created page with "{{TransitionGroup |gphash=b9203a3f7e |mz1=1583.704 |nrt=157.840 |ntransition=4 |pepnrt=use (+0.283) |peptide=PE001290 |prt=78.757 |rt=79.632 |scans=12721;EThcD;79.628;12715;15...") |
|||
Line 1: | Line 1: | ||
{{TransitionGroup | {{TransitionGroup | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|peptide=PE001290 | |peptide=PE001290 | ||
− | |||
− | |||
− | |||
|spectra=MS_48_UO1_Erlic_E12 | |spectra=MS_48_UO1_Erlic_E12 | ||
− | |||
|z1=3 | |z1=3 | ||
}} | }} |
Latest revision as of 23:11, 12 May 2021
Peptide | K.GCVLLSYLN[H5N4F3S]ETVTVSASLESVR.G (PE001290) |
---|---|
Sequence | GCVLLSYLNETVTVSASLESVR |
Glycans(s) | H5N4F3S (N9) |
Mod(s) | 57.021 (C2) |
Molecular Weight | 4,766.087 |
Charge | 3+ |
Protein | A2M (P01023) |
Spectrum File | MS_48_UO1_Erlic_E12 |
Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
Analytical Fraction | SAX-ERLICH Enrichment |
Sample | Human Serum |